US Patent Issued to Purdue Research Foundation on June 3 for "Targeting anabolic drugs for accelerated fracture repair" (Indiana Inventors)

ALEXANDRIA, Va., June 4 -- United States Patent no. 12,319,721, issued on June 3, was assigned to Purdue Research Foundation (West Lafayette, Ind.).

"Targeting anabolic drugs for accelerated fracture repair" was invented by Philip Stewart Low (West Lafayette, Ind.), Stewart A. Low (West Lafayette, Ind.) and Jeffery Jay Howard Nielsen (West Lafayette, Ind.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The targeted delivery of growth factors, vasoactive peptides and other representative anabolic peptide drugs from different signaling cascades to bone fracture for accelerated healing is disclosed herein."

The patent was filed on Dec. 2, 2022, under Application No. 18/074,275.

*For further information, includ...